A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer
He Li(Central South University), Renjun Peng(Central South University), Yuqiu Tian(Zhuzhou Central Hospital), Ziyu Dai(Central South University), Zeyu Wang(Anhui University), Hao Zhang(Northwestern Polytechnical University), Shuyu Li(Xuzhou Medical College), Nan Zhang(Huazhong University of Science and Technology), Jie Gu(Tongji University)
Cited by 6
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
|Journal of Hematology & Oncology|2020|400
PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer
|International Journal of Clinical Oncology|2017|315